Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial-Reference-Cited by-同舟云学术

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Published:2022-06 Issue: Volume:3 Page:100045
ISSN:2772-7246
Container-title:Drug and Alcohol Dependence Reports
language:en
Short-container-title:Drug and Alcohol Dependence Reports

Author:

Janzow Grace E.^ORCID,Harding Cassandra,Flores Michael,Borodovsky Jacob^ORCID,Steinkamp Jackson^ORCID,Marsch Lisa A.,Schuman-Olivier Zev^ORCID

Funder

NIDA

Publisher

Elsevier BV

Reference46 articles.

1. The effect of a payer-mandated decrease in buprenorphine dose on aberrant drug tests and treatment retention among patients with opioid dependence;Accurso;J. Subst. Abuse Treat.,2016

2. Emerging adulthood. A theory of development from the late teens through the twenties;Arnett;Am. Psychol.,2000

3. Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact;Brooklyn;J. Addict. Med.,2017

4. Gender-based outcomes and acceptability of a computer-assisted psychosocial intervention for substance use disorders;Campbell;J. Subst. Abuse Treat.,2015

5. Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19;Davis;Int. J. Drug Policy,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care;Journal of Substance Use and Addiction Treatment;2023-11